Peak Bio Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Steve LaMond
Chief executive officer
US$692.7k
Total compensation
| CEO salary percentage | 33.8% |
| CEO tenure | 2.2yrs |
| CEO ownership | 0.09% |
| Management average tenure | 1.5yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$21m |
| Mar 31 2023 | n/a | n/a | -US$18m |
| Dec 31 2022 | US$693k | US$234k | -US$13m |
| Sep 30 2022 | n/a | n/a | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$8m |
| Dec 31 2021 | US$255k | US$93k | -US$8m |
| Dec 31 2020 | US$211k | US$111k | -US$13m |
Compensation vs Market: Steve's total compensation ($USD692.68K) is about average for companies of similar size in the US market ($USD661.60K).
Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.
CEO
Steve LaMond (61 yo)
2.2yrs
Tenure
US$692,675
Compensation
Dr. Stephen LaMond, M.B.A. & Pharm D., also known as Steve, serves as Chief Operating Officer and Secretary at Peak Bio Co., Ltd. since March 01, 2022 and serves as its Interim Chief Executive Officer and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman (Leave of Absence) | no data | US$1.67m | 47.22% $ 91.9k | |
| Interim CEO | 2.2yrs | US$692.68k | 0.088% $ 170.7 | |
| Head of Oncology & Executive Director | no data | US$411.21k | 0% $ 0 | |
| Acting Chief Financial Officer | 1.5yrs | no data | no data | |
| Director of Human Resources | 1.4yrs | no data | no data | |
| Controller & Treasurer | no data | no data | no data |
1.5yrs
Average Tenure
57yo
Average Age
Experienced Management: PKBO's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.